Malignant schwannoma of the infratemporal fossa: a case report by Mohamed Mliha Touati et al.
JOURNAL OF MEDICAL
CASE REPORTS
Touati et al. Journal of Medical Case Reports  (2015) 9:153 
DOI 10.1186/s13256-015-0624-6CASE REPORT Open AccessMalignant schwannoma of the
infratemporal fossa: a case report
Mohamed Mliha Touati1*, Youssef Darouassi1, Mehdi Chihani1, Abdelfettah Al Jalil1, Khalid Tourabi2,
Mohamed Lakouichmi2, Ismail Essadi3, Brahim Bouaity1 and Haddou Ammar1Abstract
Introduction: Malignant schwannomas or neurofibrosarcomas are rare nerve tumors of unknown etiology. These
neoplasms are highly aggressive with a marked propensity for local recurrence and metastatic spread. Their
management continues to be a challenge for pathologists and surgeons. Maxillofacial locations are very
exceptional. We report the case of a patient with unusual malignant schwannoma of the infratemporal fossa
discovered at a late evolving stage.
Case presentation: A 56-year-old woman, of Moroccan nationality, presented to our hospital in 2013 with a large
right-sided hemifacial swelling that had evolved over the previous 4 months, with a limitation of mouth opening,
nasal obstruction and episodes of epistaxis. A CT scan and MRI showed a large and invasive tumor occupying her
right infratemporal fossa and maxillary sinus, with sphenoidal, ethmoidonasal, nasopharyngeal and intraorbital
extension. A nasal endoscopic biopsy was performed. Immunohistochemical examination concluded a diagnosis of
malignant schwannoma, and a palliative radiotherapy was decided; however, our patient died 10 days later.
Conclusions: Malignant schwannoma of paranasal sinuses and the anterior skull base is a rare tumor that involves
a high rate of local invasion. The prognosis is poorer compared to that occurring in the trunk and extremities.
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Malignant schwannomas or neurofibrosarcomas are
rare nerve tumors with very poor prognosis; maxillo-
facial locations are very exceptional [1]. These tumors
may be either primitive or as a complicating part of
neurofibromatosis type 1 (NF-1), also known as von
Recklinghausen’s neurofibromatosis [1]. We report an
exceptional case of malignant schwannoma of the
infratemporal fossa discovered at a late evolving stage,
with a large extension to the neighboring structures,
and discuss, through a literature review, the various
features of this tumor.
Case presentation
A 56-year-old woman, of Moroccan nationality, a
chronic cigarette smoker consuming an average of one
pack a day for 38 years, was hospitalized for a large* Correspondence: twatisimo@hotmail.com
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creativecommons.org/publicdomain/zero/1.0/right-sided hemifacial swelling. Her early symptoms
dated from 4 months previously, by the appearance of
straight facial neuralgia, treated as dental neuralgia with-
out any improvement. The evolution was marked by
rapid aggravation of the pain, which then became disab-
ling, and the emergence of a right-sided maxillary swell-
ing rapidly increasing in size and accompanied by a
limitation of mouth opening, and a nasal obstruction
with episodes of epistaxis.
A clinical examination determined a painful and in-
flammatory right-sided hemifacial swelling, right exoph-
thalmus without notion of decreased visual acuity, and
hypoesthesia at the second and third trigeminal nerve
areas. An endonasal examination detected a tumor mass
in her right nasal cavity, friable and bleeding at contact.
An oral examination, very difficult because of the limited
mouth opening, showed an erosion of the hard palate.
Cervical lymph node areas were free and an endoscopy
examination of the upper aerodigestive tract did not
show any lesions. Otoscopy and audiometry test resultsticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Fig. 2 Coronal T1-weighted magnetic resonance image of the facial
area showing an invasive tumor occupying her right infratemporal
fossa and maxillary sinus with irregular boundaries, heterogeneous
intermediary signal at T1 weight, with sphenoidal, ethmoidonasal,
nasopharyngeal extension
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immediately on morphine.
A computed tomography (CT) scan revealed the
presence of a large heterogeneous mass occupying her
infratemporal fossa as well as the masticator space
and right maxillary sinus, lysing the walls of the max-
illary sinus, the ascending branch of the mandible
and the orbital floor with ethmoidonasal, parapharyn-
geal and intraorbital extension.
A magnetic resonance imaging (MRI) scan showed an
aggressive and invasive tumor occupying her right infra-
temporal fossa and maxillary sinus with irregular bound-
aries, heterogeneous intermediary signal at T1 and T2
weight, with sphenoidal, ethmoidonasal, nasopharyngeal
and intraorbital extension. This process infiltrated the
jugal and temporozygomatic soft parts, with heteroge-
neous contrast enhancement and areas of necrosis
(Figs. 1, 2, 3, 4, 5 and 6).
A nasal endoscopic biopsy was performed. A patho-
logical examination was in favor of a malignant process,
poorly differentiated and invasive (Fig. 7). An immuno-
histochemical examination demonstrated a total cyto-
plasmic positivity to anti-S100 protein antibody,
concluding in a diagnosis of malignant schwannoma
(Fig. 8). The staging, including a cervico-thoraco-
abdominal CT scan, did not find any distant metastasis.
According to the clinical and radiological data obtained,
palliative radiotherapy was decided, delivered by a linear
electron accelerator, at a total dose of 30Gy, 10Gy by
fraction, over 3 days, with one field including the tumor
mass. The outcome was favorable with improvement ofFig. 1 Axial T1-weighted magnetic resonance image of the facial
area showing an invasive tumor occupying the right infratemporal
fossa and maxillary sinus with irregular boundaries, heterogeneous
intermediary signal at T1 weight, with sphenoidal, ethmoidonasal,
and nasopharyngeal extensionsymptoms. Unfortunately, our patient died 10 days later
after severe respiratory distress.
Discussion
Malignant schwannoma, also called neurofibrosarcoma,
neurogenic sarcoma or malignant tumor of the periph-
eral nerve sheath (malignant peripheral nerve sheath tu-
mors: MPNSTs), is a tumor of the peripheral nervous
system that develops in the nerve sheath at the expense
of Schwann cells [1]. This tumor is rare with an esti-
mated incidence of 0.1 per 100,000 per year in the gen-
eral population [1, 2].
It accounts for approximately 5 to 10 % of all soft
tissue sarcomas and has a strong association withFig. 3 Axial T2-weighted magnetic resonance image of the facial
area showing the ethmoidonasal, and intraorbital extension, with
infiltration of the jugal and temporozygomatic soft parts
Fig. 4 Coronal T2-weighted magnetic resonance image of the facial
area showing the ethmoidonasal, and intraorbital extension, with
infiltration of the jugal and temporozygomatic soft parts
Fig. 6 Coronal T1-weighted magnetic resonance image of the facial
area showing heterogeneous contrast enhancement and
necrotic areas
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neurofibromatosis. Up to 30 to 50 % of all MPNSTs
are found in association with NF-1 [2]. Radiation has
been also implicated as an etiologic factor in the de-
velopment of MPNST with a latency interval of 10 to
20 years [4]. Malignant degeneration of benign
schwannoma seems to be a rare situation and even
exceptional [2, 3].
MPNSTs represent only 2 to 6 % of head and neck sar-
comas [4], evolution of the MPNST into paranasal si-
nuses or skull base is extremely rare [3, 5].
The origin of most MPNSTs of the nose, the para-
nasal sinuses and the anterior skull base is presumed
to be the ophthalmic and maxillary divisions of theFig. 5 Axial T1-weighted magnetic resonance image of the facial
area showing heterogeneous contrast enhancement and
necrotic areastrigeminal nerve and its terminal branches, as well as
autonomic ganglia [3, 5].
These tumors primarily affect adults aged between 20
and 50, with an average of 40 years of age, without sex
predominance [2]. The forms associated with NF-1
occur late and affect mainly men [2, 3].
Clinically, MPNSTs generally are presented as a pro-
gressively enlarging and painful mass in the paranasal
sinus or anterior skull base. Malignant schwannomas
may become clinically apparent with unilateral nasal ob-
struction, hyposmia, epistaxis, atypical pain, hypoesthe-
sia or localized swelling of the facial and orbital region,
mucopurulent rhinorrhoea and headache [6].
Exophthalmus, epiphora and progressive visus reduction
are less frequently described and are principally related to
neoplasms of the orbital compartment. Intracranial exten-
sion has also been reported [5, 6].Fig. 7 Malignant tumoral proliferation, poorly differentiated and
infiltrating. (H&E × 100)
Fig. 8 Positive and diffuse cytoplasmic immunostaining of tumor
cells anti-S100 protein antibody, confirming the diagnosis of
malignant schwannoma. (H&E × 200)
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adequate imaging investigation for schwannomas of
paranasal sinuses [7]. CT, however, is crucial to a pre-
operative surgical plan, revealing the pushing borders of
the tumors, rather than the invasive character of malig-
nancy [7, 8]. There is generally no bone development;
erosion of the neighboring bone structures may rarely be
observed secondarily to necrosis caused by the pressure
of the growing mass [7]. MRI with gadolinium contrast
may provide more useful information, and is indicated
in areas with intraorbital or intracranial extension, and
for more exact delineation of the tumor from normal
soft tissue. Even in situations where the schwannoma is
confined within the sinuses and nasal cavity, MRI is
helpful in differentiating the neoplasm from retained se-
cretions or inflammatory changes [8].
Microscopically, MPNSTs are highly cellular, focally
polymorphic tumors compounded of spindle cells ar-
ranged in bundles or fascicles with high mitotic rates, in-
distinct cytoplasmic borders and a variable degree of
nuclear pleomorphism [5, 9].
MPNSTs can be histologically similar to other malig-
nant tumors, particularly malignant melanoma and other
spindle cell sarcomas. Currently, immunohistochemical
analysis especially, but also the recognition of Schwann
cells by electron microscopy, help identify MPNSTs [9,
10]. In immunohistochemical analysis, the majority of
MPNSTs express the neuroectodermal marker S-100
protein and the mesenchymal marker vimentin, while
cytokeratin and desmin are rarely identified [9, 10].
A literature review by Pfeiffer, revealed that of 33 well-
documented cases of MPNSTs localized in the anterior
skull base or the paranasal sinuses published since 1971
[10], only nine cases had MPNSTs in both locations (as
our patient).
Management of MPNSTs has often been reported
to be challenging, especially in the head and neck, soearly diagnosis is indispensable. The recommended
treatment of MPNSTs is surgical extirpation including
wide margins, and involved nerves should be followed
proximally in an attempt to obtain clear margins.
Regional nodal dissection is not recommended. The
surgical approach depends upon the location and the
extent of the tumor [11].
The role of radiotherapy and chemotherapy in the
treatment of this tumor is still controversial. MPNST
has traditionally been described as being highly radiore-
sistant, but, some recent reports recommend the use of
postoperative radiotherapy, but there is no clear evi-
dence of definite advantage [10, 11].
For our patient, the location of the tumor in the infra-
temporal fossa and the large infiltration of neighboring
structures made it difficult to perform surgery, and treat-
ment was limited to radiotherapy.
MPNST is a very aggressive tumor that spreads via
direct perineural invasion and the hematogenous route.
The local recurrence rate is about 54 % and the rate of
distant metastases to lung and bone is about 65 %.
Lymph node involvement is not common [6, 11].
The prognosis of MPNSTs of the head and neck is
relatively poorer than that of MPNSTs of the extremities
and the trunk with documented 5-year survival rates
from 15 to 35 % [2, 11], these tumors have even closer
proximity to vital structures making local control by rad-
ical resection more critical. Due to the anatomical
location, en bloc resection is often impossible and frac-
tional excision is common.Conclusions
MPNST of the paranasal sinuses and the anterior skull
base is a rare tumor that involves a high rate of local in-
vasion, distant spread, and local recurrence.
The management of this aggressive neoplasm in this
anatomical location remains an interdisciplinary challenge.
A good outcome is mainly a function of local control by
means of surgical resection. The prognosis is poorer com-
pared to that occurring in the trunk and extremities.Consent
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